Latest Breaking News On - Biosciences company profile - Page 9 : comparemela.com

IGM Biosciences, Inc (NASDAQ:IGMS) Receives Average Recommendation of Hold from Brokerages

IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) has earned a consensus recommendation of “Hold” from the eight research firms that are presently covering the company, MarketBeat reports. Five equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12 month target […]

Royal bankRaymond james associatesUs bancorpSwiss national bankBiosciences company profileIgm biosciences incBiosciences incMorgan stanleyJpmorgan chase coGet free reportNational bankRhumbline advisersGet freeDigm biosciencesNasdaq igms

JPMorgan Chase & Co Increases IDEAYA Biosciences (NASDAQ:IDYA) Price Target to $41 00

IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its price objective increased by JPMorgan Chase & Co. from $35.00 to $41.00 in a research note published on Thursday, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. Several other analysts also recently commented on IDYA. SVB Securities assumed coverage on IDEAYA […]

Hong kongLeerink partnrsChina universal asset management coBiosciences incBiosciences company profileJpmorgan chase coLife insurance coHong kong ltdSecurities exchange commissionRoyal bankFree reportGet free reportJason throneExchange commissionKong ltdUniversal asset management

Royal Bank of Canada Boosts IDEAYA Biosciences (NASDAQ:IDYA) Price Target to $36 00

IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its price target increased by Royal Bank of Canada from $32.00 to $36.00 in a research report sent to investors on Tuesday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. A number of other brokerages also recently commented on IDYA. JPMorgan […]

United statesLeerink partnrsRoyal bankHalpern financial incBiosciences incSg americas securitiesTucker asset managementBiosciences company profileGoldman sachs groupYork mellon corpJpmorgan chase coFree reportGet free reportJason throneNew york mellon corpAsset management

IDEAYA Biosciences (IDYA) Outperform Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada restated their outperform rating on shares of IDEAYA Biosciences (NASDAQ:IDYA – Free Report) in a research note published on Wednesday morning, Benzinga reports. The firm currently has a $32.00 target price on the stock. IDYA has been the topic of a number of other research reports. Oppenheimer raised their target price […]

Hong kongLeerink partnrsGoldman sachs groupBiosciences incRoyal bankSecurities exchange commissionAllspring global investments holdingsHong kong ltdBiosciences company profileLife insurance coFree reportStock downGet free reportJason throneExchange commissionKong ltd

IDEAYA Biosciences (NASDAQ:IDYA) Shares Gap Up on Analyst Upgrade

IDEAYA Biosciences (NASDAQ:IDYA) Shares Gap Up on Analyst Upgrade
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Leerink partnrsBiosciences company profileBiosciences incVanguard group incBlackrock incGoldman sachs groupGet free reportJason thronePartners managementStreet corpVanguard groupStock down